May 2012 Awards
Altschuler, Steven, NIH, Lung Cancer Heterogeneity and Its Impact on Drug Resistance, $453,829; Amatruda, James, Univ. of Minnesota/NIH, Molecular Epidemiology of Pediatric Germ Cell Tumors, $11,507; Arnoldo, Brett, American Burn Assn./DOD, Clinical Trial of Restrictive vs. Traditional Blood Transfusion Practices in Burn Patients, $10,000; Baker, Linda, NIH, Near Infrared Spectroscopy for Pediatric Acute Scrotum and Testicular Torsion, $238,250; Barton, Theresa, Texas Dept. of Health/HRSA, HIV Perinatal Transmission Prevention, $63,158; Beutler, Bruce, Scripps Research Inst./NIH, Discovery and Analysis of Synthetic TLR Agonists and Antagonists, $286,620; Bibb, James, NIH, NMDA Receptor Regulation in Addiction, $317,666; Bowers, Daniel, St. Jude Children’s Research Hosp./NIH, Childhood Cancer Survivor Study, $9,759; Brown, E. Sherwood, NIH, Citicoline for Bipolar Disorder and Cocaine Dependence - Summer Supplement, $6,156; Browning, Jeffrey, NIH, Role of Mitochondrial Dysfunction in Non-Alcoholic Fatty Liver Disease, $35,689.
Burstein, Ezra, NIH, Gastroenterology/Hepatology Research Training Program, $240,818; Cannon, Carolyn, Univ. of Akron/NIH, Collaborative Research: Polymeric Drug Delivery Systems and Biofilms in the Lung, $40,304; Cannon, Carolyn, Univ. of Akron/NIH, Collaborative Research: Polymeric Drug Delivery Systems and Biofilms in the Lung, $39,246; Cannon, Carolyn, Univ. of Akron/NIH, Collaborative Research: Polymeric Drug Delivery Systems and Biofilms in the Lung, $23,711; Carson, Jo Ann, Univ. of North Texas HSC/NIH, Evaluating Community Engaged Program to Reduce Obesity in Hispanic Families, $20,621; Castillo, Leticia, NIH, Parenteral Methionine Requirements in Septic Children, $345,553; Chen, David, Univ. of Calif., Berkeley/NIH, Structural Cell Biology of DNA Repair Machines, $80,242; Conrad, Nicholas, NIH, Mechanisms of KSHV Post-Transcriptional Gene Regulation, $314,573; Conrad, Nicholas, NIH, Mechanisms of KSHV Post-Transcriptional Gene Regulation-Diversity Supplemental, $61,720; Cowell, Lindsay, Duke Univ./NIH, Multiscale Systems Immunology, $38,891.
Dowling, Michael, Med. Univ. of S. Carolina/NIH, TCD with Transfusions Changing to Hydroxurea (TWiTCH), $50,000; Dozmorov, Igor, Univ. of Florida/NIH, B Cell Development Defects in Murine Lupus, $6,891; Eisch, Amelia, NIH, Basic Science Training Program in Drug Abuse, $423,237; Eisch, Amelia, NIH, Opiates and Adult Neurogenesis-Diversity Supplement Latchney, $88,617; Elmquist, Joel, Massachusetts Gen. Hosp./NIH, Neuroendocrine Response to Gastric Bypass in Nonhuman Primates-ARRA Stimulus RC4, $210,120; Elmquist, Joel (C. Javadi, Fellow), NIH, Leptin and Insulin Responses in Hypothalamic NPY Neurons, $29,412; Falck, J. Russell, Vanderbilt Univ./NIH, Role of Icosanoids in Renal Function-Core C, $160,870; Falck, J. Russell, New York Med. Coll./NIH, Hormonal Regulation of Blood Pressure, $137,517; Farrar, John (S. Gonzales, Fellow), NIH, Role of Type I Interferon in Allergic Asthma, $29,455; Garcia, Joseph, NIH, Molecular Mechanisms Dictating Sirt1/HIF-2 Signaling During Hypoxia, $339,688.
Garrard, William, NIH, Function of Subunits of Eukaryotic Chromosomes, $310,640; Goldberg, Matthew, NIH, Biophysical Analysis of LRRK2 (MPI), $193,175; Graff, Jonathan, NIH, Hormonal Regulation of Fat Deposition, $490,513; Graff, Jonathan, NIH, Adipocyte Development: Lineage Analysis and Molecular Characterization, $369,302; Hansen, Eric, NIH, Surface Proteins of Moraxella Catarrhalis, $34,622; He, Yu-Guang, Emmes Corp./NIH, Age-Related Eye Disease Study 2 (AREDS2), $1,617; Hooper, Lora, NIH, Bacterial Regulation of Intestinal Antimicrobial Defense, $326,369; Hooper, Lora (B. Duerkop,), NIH, Interactions of Commensal Bacterium with Intestinal Mucosal Surface, $53,942; Hsieh, Jenny, NIH, Genome-Wide Profiling of REST/NRSF Targets in Adult Neural Stem Cells, $198,594; Hsieh, Jer-Tsong, U.S. Dept. of Defense, Suppression of BRCA2 by Mutant Mitochondrial DNA in Prostate Cancer, $230,820; Huang, Hao, NIH, Structural Development of Human Fetal Brain, $358,298.
Jarrett, Robin, NIH, 1/2 Preventing Perinatal Depression (PRE-D): Developing Tools and Interventions (MPI), $238,438; Jiang, Qiu-Xing, NIH, Structural Study of a Kv Channel in Different Conformations in Membranes, $298,844; Johnson, Jane, NIH, Regulation and Function of Asc11 in Neural Development, $347,630; Journeycake, Janna, UTHSC-Houston/NIH, Region VI Comprehensive Hemophilia Center, $39,061; Journeycake, Janna, UTHSC-Houston/CDC, Public Health Surveillance for Prevention of Complications of Bleeding and Clotting Disorders, $19,161; Karandikar, Nitin, NIH, CNS-Specific Regulatory CD8+ T Cells in Autoimmune Demyelination, $357,375; Kavalali, Ege, NIH, Light-Induced Reversible Manipulation of Neurotransmitter Release, $198,541; Koch, Joshua, Univ. of Michigan/NIH, Therapeutic Hypothermia after Pediatric Cardiac Arrest; THAPCA Trials, $23,293; Kraus, William, NIH, Role of PARP-1 in Hormone-Regulated Transcription, $309,958; Kraus, William, Univ. of Rochester/NIH, Environmental Influences on Epigenetic Immune Programming, $18,664.
Kutz, Joe, Nationwide Children’s Hospital/NIH, Virtual Temporal Bone Surgery: Defining and Translating Standardized Metrics to Automated Assessment Tool, $8,500; Le, Lu, NIH, Roles of Tumor Microenvironment in Neurofibroma Development and Therapeutics, $329,579; Lehrman, Mark, NIH, N-Glycosylation and ER Stress, $403,984; Leitch, Marilyn, Duke Univ./NIH, ACOSOG Admin Coordinating Ctr; Site 119, $3,250; Levine, Beth, UT Medical Branch at Galveston/NIH, Autophagy-Inducing Peptide as Novel Therapeutic for Intracellular NIAID Pathogens, $449,641; Li, Wen-Hong, NIH, Photonic Probe and Techniques for Biological Imaging Applications, $333,638; Lin, Weichun, NIH, Patterning and Formation of Neuromuscular Junction, $347,447; Lister, George, Boston Univ. Med. Ctr./NIH, Study of Attitudes and Factors Affecting Infant Care, $23,018; Lotan, Yair, UT M.D. Anderson/NIH, Aurora Kinase A as Biomarker for Detection of Bladder Cancer, $40,000.
Markham, David, Univ. of Pittsburgh/NIH, Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy-ARRA Stimulus Funding, $400; McCavit, Timothy, Washington Univ. in St. Louis/NIH, Silent Cerebral Infarct Multicenter Clinical Trial, $6,989; McPhaul, Michael, NIH, Minority Predoctoral NLHBI Research Training at UT Southwestern, $118,364; Meeks, Julian, NIH, Functional Organization of Neural Circuits in Mouse Accessory Olfactory Bulb, $248,889; Mohan, Chandra, NIH, Immunogenetics of Antibody Induced Nephritis, $328,268; Morris, David, NIH, e-MBC for Major Depressive Disorder (MPI), $79,416; Morrison, Sean, NIH, Stem Cells in Peripheral Nervous System Development, $254,758; Mosconi, Matthew, NIH, Motor Control and Cerebellar Maturation in Autism, $157,148; Muppidi, Srikanth, Univ. of Miami/FDA, Effectiveness of Prednisone for Treatment of Ocular Myasthenia (EPITOME), $6,195; Nesbitt, Shawna, Minneapolis Med. Research Fndtn./NIH, ASPirin in Reducing Events in Elderly, $500.
Olson, Eric (D. Quiat, Fellow), NIH, Role of miR-210 in Cardiomyocyte Metabolism Following Myocardial Infarction, $30,325; Otwinowski, Zbyszek, NIH, Crystallography of Macromolecules, $323,305; Pascual, Juan, NIH, Modulation of Neural Function in Energy Failure, $347,630; Paulk, Elizabeth, Dana-Farber Cancer Inst./NIH, Black-White Differences in Advanced Cancer Communication, Acceptance and Care, $89,269; Quiceno, Mary, Univ. of Calif., San Diego/NIH, Alzheimer’s Disease Cooperative Study-Infrastructure Support, $49,999; Raskin, Philip, NIH, Pioglitazone Preserves Insulin Secretion in Type 1 Diabetes, $492,144; Rockey, Don, NIH, Nitric Oxide and Cellular Pathogenesis of Portal Hypertension, $334,680; Rogers, Zora, NIH, Baby HUG Follow-Up Study II, $192,524; Rothermel, Beverly, NIH, Modulating Calcineurin Signaling Pathways in Muscle, $388,575; Sanchez, Pablo, Duke Univ./NIH, Fluconazole Prophylaxis for Prevention of Candidiasis in Infants <750 grams="" birth="" weight="" 1="" 000="" p="">
Scaglioni, Pier, NIH, Characterization and Drug Targeting of PML Tumor Suppressor in Lung Cancer, $316,002; Self, David (A. Nugent, Fellow), NIH, Differential Changes in Dopaminoceptive Neurons During Cocaine Withdrawal, $53,942; Shaul, Philip, NIH, Oxysterols, Estrogen Receptor Antagonism and Vascular Disease, $392,288; Sherry, Dean, NIH, Metabolism in the Heart by NMR, $388,575; Souza, Rhonda, NIH, Role of Acid in Development of Barrett's Esophagus, $274,050; Sperandio, Vanessa, NIH, AI-3 Inhibitors as Treatment for Bacterial Infections-Entire Project, $1,075,870; Sternweis, Paul, NIH, Signal Transduction via Receptors and G Proteins, $50,074; Sweeney, John, Univ. of Maryland/NIH, Clinical and Computational Studies of Dopamine Function in Schizophrenia, $174,300; Sweeney, John, Univ. of Georgia/NIH, Neural Mechanisms for Antisaccade Errors Among Schizophrenia Families, $152,896; Tamminga, Carol, NIH, Antipsychotic Influence on Altered MTL Neuronal Activity in Schizophrenia, $38,857.
Trivedi, Madhukar, NIH, Clinical Trial Network: North Texas Node-Protocols 37 STRIDE, 44 Web-Delivery, 46 S-CAST, and 48 CURB, $1,632,000; Trivedi, Madhukar, NIH, Clinical Trial Network: North Texas Node-Protocols 49 HOPE and 52 BRAC, $671,426; Turley, Stephen, NIH, Disordered Cellular Cholesterol Movement, Cell Death, and Multisystem Disease, $868,830; Ward, Sally, NIH, Mechanistic Studies of FcRn Inhibitors for Treatment of IgG-Mediated Diseases, $328,268; Winick, Naomi, Natl. Childhood Cancer Fndtn./NIH, COG Chair Grant; Methotrexate Supplemental, $224,779; Winick, Naomi, Children’s Oncology Group/NIH, COG Chair Grant PCR; #1233, $1,700; Xu, Che, NIH, Xenogenic Scaffolds for Repair of Acute Vocal Fold Lamina Propria Injury, $153,791; Yanagisawa, Hiromi, NIH, Protease Regulation and Integrity of Connective Tissues of Pelvic Floor, $316,479; Zhang, Chun-Li, NIH, Transcriptional Control of Adult Neural Stem Cells, $347,447.
Argenbright, Keith, Univ. of North Texas HSC/CPRIT, Rural Texas Physician Cancer Screening Education Program in High-Risk Cancer Cluster Regions, $7,500; Cobb, Melanie, CPRIT, P1: Coordination of Inputs from Taste Receptors and Ras/ERK1/2 Axis to mTORC1: Mechanisms and Pathway Interactions in Cancer, $405,000; Gao, Jinming, CPRIT, Beta-Lapachone Nanotherapeutics for NQO1-Targeted Therapy of Cancer, $325,877; Herz, Joachim, Univ. of Calif., San Francisco, Consortium for Frontotemporal Dementia Research, $242,000; Hooper, Lora (J. Benjamin, Fellow), UNCF-Merck Science Initiative, Role of Autophagy in Maintaining Homeostasis with Gut Microblots, $38,008; Jain, Raksha, Seattle Children’s Research Inst./Cystic Fibrosis Fndtn., G551D Observational Study, $23,858; Khazzam, Michael, Arthroscopy Assn. of North America, Acute vs. Chronic (Delayed) Rotator Cuff Repair in Rat Model, $18,600; Kraus, William (S. Gadad, Fellow), Susan G. Komen for the Cure, Role of PARP-1 in Regulating Gene Expression in Breast Cancer Cells, $60,000.
Li, Shuxin, Christopher Reeve Fndtn., Novel Regenerative Therapeutics for Spinal Cord Injury, $75,000; Moldrem, Amy, Susan G. Komen for the Cure, Genetic Awareness and Testing for Hereditary Breast Cancer, $50,000; Nguyen, Benjamin (R. Araim, Fellow), Medtronic Neuromodulation, Medtronic Spasticity Management Fellowship, $15,000; Nijhawan, Ank, Beth Israel Deaconess Med. Ctr./ASTDA, Prevalence and Predictors of Trichomonas Infection in Incarcerated Women, $30,204; Noe, Carl, Boston Scientific Neuromodulation, Boston Scientific Pain Fellowship Grant, $10,000; Olson, Eric (P. da Costa Martins, Fellow), Fondation Leducq, MiR-216a: Cell Death-Regulating microRNA During Myocardial Repair, $150,000; Story, Michael, CPRIT, P1: Enhancing Identification of Markers and Potential Therapeutic Targets for Improving Tumor Response via MIRNA and DNA Methylation Analysis (lead UT M.D. Anderson), $276,232.
Industry Sponsored Awards, dollar amounts not available
Anderson, Matthew, Study of FLUENCY PLUS Endovascular Stent Grant in Treatment of In-Stent Restenosis in AV Access Venous Outflow Circuit (RESCUE); Brekken, Rolf, Evaluating Biology and Therapeutic Mechanism of NEO-201 and NEO-301; Brown, E. Sherwood, Study of Lurasidone Adjunctive to Lithium or Divalproex for Prevention of Recurrence in Subjects with Bipolar I Disorder; Chan, Danny, Ph3 Investigation of Hepasphere/Quadrasphere Microspheres for Delivery of Doxorubicin for Treatment of Hepatocellular Cancer; Haley, Barbara, Ph2 Study of Veliparib w/Temozolomide or Veliparib w/Carboplatin and Paclitaxel vs Placebo plus Carboplatin and Paclitaxel in Subjects w/BRCA1 or BRCA2 Mutation and Metastatic Breast Cancer; Jain, Mamta, Ph3 Study of Telaprevir in Combination w/ Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Subjects with Genotype 1 HCV and HIV-1; Joglar, Jose, Ph3 Study of Once-Daily Oral Doses of 75 mg Azimilide Dihydrochloride on Incidence of CV Hospitalizations/ER Visits or CV Death in Patients with Implantable Cardioverter Defibrillator.
McPhaul, Michael, Ph3 Study of Pasireotide LAR in Patients with Cushing’s Disease; Raskin, Philip, Ph3 Study of Ranolazine Monotherapy in Subjects with Type 2 Diabetes Mellitus; Stuve, Olaf, ATP (Alternative Treatment Paradigm for Natalizumab) Trial; Vusirikala, Madhuri, Study of ECP Therapy with UVADEX for Treatment of Patients with Moderate-Severe Chronic Graft vs. Host Disease (cGvHD); Wolf, Steven, Dose-Escal Study of Stratagraft Skin Tissue in Promoting Healing of Deep Partial-Thickness Component of Complex Skin Defects.